Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable...

Ogkologos - 9 Φεβρουαρίου, 2026

EMA Recommends Extension of Therapeutic Indications for Retifanlimab

Ogkologos - 6 Φεβρουαρίου, 2026

Adding Palbociclib to Maintenance Anti-HER2 and Endocrine Therapies Improves PFS Over...

Ogkologos - 5 Φεβρουαρίου, 2026

FDA Grants Traditional Approval to Pirtobrutinib for Chronic Lymphocytic Leukaemia and...

Ogkologos - 4 Φεβρουαρίου, 2026

ESMO Launches Its Roadmap 2030 to Support Oncology Professionals and Foster...

Ogkologos - 4 Φεβρουαρίου, 2026

Nous-209 Efficiently Stimulates Immunity Against Neoantigens in Lynch Syndrome Carriers

Ogkologos - 3 Φεβρουαρίου, 2026

2026 ESMO TAT Honorary Award Recipient Announced

Ogkologos - 3 Φεβρουαρίου, 2026

2026 Heine H. Hansen Award Recipient Announced

Ogkologos - 3 Φεβρουαρίου, 2026

Longer RFS with Nivolumab Than with Ipilimumab Among Patients with Resected...

Ogkologos - 2 Φεβρουαρίου, 2026

Sacituzumab Govitecan Plus Pembrolizumab Prolongs PFS Among Patients with Previously Untreated,...

Ogkologos - 30 Ιανουαρίου, 2026

1...262728...440 Σελίδα 27 από 440

MOST POPULAR

Can Getting a Tattoo Cause Cancer?

4 Μαΐου, 2021

After Spine Tumor, Teacher Goes On Mission To Serenade Hospital Patients...

24 Ιουνίου, 2019

Researchers Turn On PTEN Tumor-Suppressor Protein in Cancer Cells

14 Ιουνίου, 2019

Creating a shared vision to detect cancer earlier

15 Οκτωβρίου, 2020

Φόρτωση περισσοτέρων

PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable...

EMA Recommends Extension of Therapeutic Indications for Retifanlimab

Adding Palbociclib to Maintenance Anti-HER2 and Endocrine Therapies Improves PFS Over...

FDA Grants Traditional Approval to Pirtobrutinib for Chronic Lymphocytic Leukaemia and...

ESMO Launches Its Roadmap 2030 to Support Oncology Professionals and Foster...

Nous-209 Efficiently Stimulates Immunity Against Neoantigens in Lynch Syndrome Carriers

2026 ESMO TAT Honorary Award Recipient Announced

2026 Heine H. Hansen Award Recipient Announced

Longer RFS with Nivolumab Than with Ipilimumab Among Patients with Resected...

Sacituzumab Govitecan Plus Pembrolizumab Prolongs PFS Among Patients with Previously Untreated,...

MOST POPULAR

Can Getting a Tattoo Cause Cancer?

After Spine Tumor, Teacher Goes On Mission To Serenade Hospital Patients...

Researchers Turn On PTEN Tumor-Suppressor Protein in Cancer Cells

Creating a shared vision to detect cancer earlier

HOT NEWS

FDA Approves Neoadjuvant and Adjuvant Pembrolizumab for Resectable Locally Advanced Head...

Addition of an EGFR Antibody to Fluorouracil/Folinic Acid Maintenance Therapy in...

Activity of Targeted/Immune Therapy Approach in Patients with Advanced Urothelial Cancer

Molecular Analysis for Precision Oncology Congress 2025, Paris, France, 15-16 September

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ